Unverified50% confidenceFactExact time
Semaglutide is a representative GLP-1 receptor agonist drug, initially used to treat type 2 diabetes and later widely used for weight management due to its weight-loss effects.
1
Sources
50%
Confidence
Long-term
Relevance
10/20/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedGLP-1 receptor agonists mimic the action of the body's natural glucagon-like peptide-1 (GLP-1), promoting insulin release, inhibiting glucagon secretion, delaying gastric emptying, and acting on the central nervous system to produce a sense of fullness.62% similarUnverifiedA company has developed a viral vector carrying the GLP-1 gene that uses the insulin gene promoter of beta cells to enable patients to simultaneously secrete GLP-1 when secreting insulin, and it has entered the clinical trial stage.61% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1077913API
curl https://kongchang.com/api/v1/knowledge/claims/1077913MCP
get_claim(id=1077913)